CORE 2019

A consultant cadiologist at John Radcliffe Hospital, Oxford University, Oxford, UK. Features in 13 videos on Wondr Medical. Adrian Banning generally speaks on Bifurcation, Left Main Stem (LMS), Intravascular Ultrasound (IVUS), Coronary Optical Coherence Tomography (OCT), and Multi Vessel Disease.

An interventional cardiologist at John Radcliffe Hospital, Oxford University, Oxford, UK. Features in 4 videos on Wondr Medical. Andrew Lucking generally speaks on Primary Percutaneous Coronary Intervention (PPCI), Bifurcation, Chronic Total Occlusion (CTO), Coronary Interventions, and Anti-Platelet Drugs .

A consultant cardiologist at Golden Jubilee National Hospital, Clydebank, UK. Features in 1 video on Wondr Medical. Colin Berry generally speaks on Invasive Imaging, Other, Coronary Physiology, and IMR.

A consultant cardiologist at Mater Private Hospital, Dublin, Ireland. Features in 20 videos on Wondr Medical. Colm Hanratty generally speaks on Fractional Flow Reserve (FFR), Intravascular Ultrasound (IVUS), Chronic Total Occlusion (CTO), Calcium Scoring, and Stable Coronary Artery Disease (CAD).

An interventional cardiologist at Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom. Features in 2 videos on Wondr Medical. Colum Owens generally speaks on Multi Vessel Disease, Coronary Interventions, Stable Coronary Artery Disease (CAD), and Transcatheter Aortic Valve Implantation (TAVR / TAVI).

An industry at Boston Scientific, Natick, Massachusetts, USA. Features in 5 videos on Wondr Medical. Craig Thompson generally speaks on Chronic Total Occlusion (CTO), Coronary Interventions, Covid-19, Covid19 Webinars and Discussions, and Stable Coronary Artery Disease (CAD).

An interventional cardiologist at Sahlgrenska University Hospital/Östra Hospital, Göteborg, Sweden. Features in 1 video on Wondr Medical. Dan Ioanes generally speaks on Multi Vessel Disease, Chronic Total Occlusion (CTO), Coronary Artery Bypass Grafting (CABG), and Coronary Interventions.

Dr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology of the Piedmont Heart Institute; and Chief Scientific Officer for Piedmont Healthcare in Atlanta, Georgia. Dr. Kandzari specializes in cardiovascular disease, peripheral arterial disease and interventional cardiology. A graduate of Duke University School of Medicine, he completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. Dr. Kandzari is the former Director of Interventional Cardiology Research at the Scripps Clinic in La Jolla, California. Before joining the Scripps faculty, he also served as Chief Medical Officer for the Cordis Corporation, a Johnson & Johnson Company. He has also served as a Medical Officer for the Center for Devices and Radiological Health for the United States Food and Drug Administration. Board certified by the American Board of Internal Medicine and its subspecialty Board of Cardiovascular Disease and Board of Interventional Cardiology, Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 400 studies, book chapters and scientific reviews, and has delivered more than 700 lectures, both nationally and internationally, on a variety of issues related to both interventional and general cardiology. Dr. Kandzari has been consecutively voted as one of Atlanta's Top Doctors by Atlanta Magazine from 2011 to 2021, and is peer-nominated in the top 1% of cardiologists by U.S News and World Report.

Works at Aarhus University Hospital, Skejby, Denmark. Features in 3 videos on Wondr Medical. Evald Christiansen generally speaks on Primary Percutaneous Coronary Intervention (PPCI), Coronary Artery Bypass Grafting (CABG), Left Main Stem (LMS), Coronary Physiology, and Bifurcation.

Dr. Farouc Jaffer graduated from Stanford University in 1990 with a B.S. in Mathematical and Computational Sciences, and received in MD and PhD in Biophysics from the University of Pennsylvania of Medicine in 1996. He completed a residency in internal medicine at the Brigham and Women's Hospital, followed by a fellowship in cardiovascular medicine and interventional cardiology at Massachusetts General Hospital. In 2003, he joined the Cardiology Division as faculty. Dr. Jaffer is currently an Associate Professor of Medicine at Harvard Medical School and an Attending Interventional Cardiologist at Massachusetts General Hospital. He is Director of Coronary Intervention and Director of the Chronic Total Occlusion (CTO) PCI Program at at Massachusetts General Hospital. The MGH is a leading center for treating the most complex coronary blockages, such as CTO. Many patients, previously without options, have successfully underwent CTO PCI, and have experienced marked reductions in angina (chest pain) and shortness of breath. Dr. Jaffer is also a Principal Investigator in the MGH Cardiovascular Research Center where his NIH-funded laboratory develops novel molecular imaging approaches to image high-risk plaques and blood clots, to better prevent heart attacks, strokes, and venous blood clots.

Dr. James (Jamie) McCabe graduated magna cum laude from Bowdoin College and received his medical degree from Yale University. He completed 10 years of post-medical school training including internal medicine training and general cardiology fellowship at University of California, San Francisco (UCSF) and interventional cardiology fellowship as well as an advanced interventional fellowship in structural and peripheral treatments at Brigham and Women's Hospital / Harvard Medical School. He is board certified in Internal Medicine, Cardiology, and Interventional Cardiology. Dr. McCabe is currently the Section Chief of Interventional Cardiology and Medical Director of the Cardiac Cath Labs at the University of Washington in Seattle, WA. He is a nationally recognized clinician educator and investigator in transcatheter therapies for valvular heart disease and coronary artery intervention.

James Spratt Professor of Interventional cardiology with a sub-speciality interest in complex PCI, intravascular imaging and CTO. He is widely published within this area and has performed live case demonstrations globally. He has an interest in medical education and is the Founder of Optima Education.

A consultant cardiologist at King's College Hospital, London, UK. Features in 2 videos on Wondr Medical. Jonathan Byrne generally speaks on Chronic Total Occlusion (CTO), Impella, Coronary Interventions, Covid19 Webinars and Discussions, and Covid-19.

Consultant Interventional Cardiologist and Revascularisation Group Chair at Royal Brompton Hospital, London. His clinical focus is on use of intravascular imaging in complex PCI , CTO and cardiogenic shock. His clinical research interests focus on optical coherence tomography, calcific coronary disease and percutaneous ventricular support. Dr Hill was global co-chief investigator for the DISRUPT CAD III study and has served as UK principal investigator for multiple interventional trials. He has served as a CTO and complex PCI proctor on a global basis and works closely with OPTIMA to focus on the development of OPTIMAL PCI. He is the founding co-director of the Complete Revascularisation (CoRe) meetings held every year in London.

Dr Julian Strange is a consultant interventional cardiologist at Bristol Heart Institute, UK. His specialty and research interests are in coronary disease and include coronary angioplasty, complex PCI and chronic total occlusions (CTO) as well as advanced heart attack and cardiac arrest therapies.

An interventional cardiologist at Kings College London, UK. Features in 4 videos on Wondr Medical. Julian Yeoh generally speaks on Primary Percutaneous Coronary Intervention (PPCI), Bifurcation, Chronic Total Occlusion (CTO), Left Main Stem (LMS), and Coronary Interventions.

Dr Justin Davies is a honorary 
interventional cardiologist at Hammersmith Hospital, Imperial College NHS Trust, London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to
work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents,
he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies).

Keith Oldroyd is a cardiologist.

After training in Scotland, Interventional Cardiology Fellowship at CUMC, and Clinical Research Fellowship at Harvard University, she was a Consultant Interventional Cardiologist at the Golden Jubilee National Hospital and Associate Professor of Cardiology at the University of Glasgow, prior to moving back to New York in 2022.

A consultant cardiologist at Wessex Cardiothoracic Unit, Southampton University Hospital, Southampton, UK. Features in 14 videos on Wondr Medical. Nick Curzen generally speaks on Covid19 Managing Covid, Coronary Interventions, Left Main Stem (LMS), Anti-Platelet Drugs , and Drug Eluting Stents (DES).

An interventional cardiologist at Liverpool Heart and Chest Hospital, Liverpool, UK. Features in 4 videos on Wondr Medical. Rod Stables generally speaks on Chronic Total Occlusion (CTO), Coronary Interventions, Anti-Platelet Drugs , and Drug Eluting Stents (DES).

An interventional cardiologist at Sandwell and West Birmingham Hospitals NHS Trust. Features in 1 video on Wondr Medical. Shamim Rahman generally speaks on Coronary Artery Bypass Grafting (CABG) and Coronary Interventions.

Dr Simon Walsh has been working as a Consultant Cardiologist at the Belfast Trust for over 10 years. It is one of the largest NHS trusts in the UK. The centre performs ~2750 PCI per year, with 650-700 STEMI and calcium modification in ~10% of our PCI cases. Dr Walsh also works internationally as an educator, teaching advanced techniques for complex PCI and CTO PCI. This involves training visiting Cardiologists in Belfast retrograde CTO techniques, antegrade dissection and re-entry CTO techniques and other advanced PCI procedures. He has visited multiple centres in the UK, Ireland, Europe, Australia, Asia and North America to act as a visiting proctor for complex PCI and CTO PCI cases. Dr Walsh’s research interests include PCI, coronary artery disease, defibrillation, acute coronary syndromes and chronic total occlusions. Research responsibilities have included acting as a recruiting investigator for the >25 multicentre studies over the last 17 years. He acted as a primary investigator for numerous international trials including the Evolve, Noble, Leaders Free and Ischemia multicentre studies. He has been the lead UK investigator for the October trial, Syntax 2, Recharge and Ischaemia-CTO. He is also the Chief Investigator for the Consistent CTO, Celtic Bifurcation and Discrete CTO trials.

An interventional cardiologist at St George's Hospital, London UK. Features in 12 videos on Wondr Medical. Simon Wilson generally speaks on Chronic Total Occlusion (CTO), Primary Percutaneous Coronary Intervention (PPCI), Coronary Artery Bypass Grafting (CABG), Coronary Interventions, and Multi Vessel Disease.

Dr Tom Johnson is an interventional cardiologist and recently appointed Associate Professor at the Bristol Heart Institute & University of Bristol, UK. He is an active member of the EAPCI, currently sitting on the Education & Training, and the Scientific programme committees, with responsibilities for writing the new interventional curriculum and exam. He is a member of the European Bifurcation Club, the ESC ACCA SCAD study group, co-authoring the European position paper, and sits on the UK Societi scientific committee for Kawasaki disease. His academic interests include developing the role of intracoronary imaging in PCI, optimising bifurcation results and platelet pharmacology in acute coronary syndromes. He plays an active role in local, national, and international educational initiatives in developing PCI skills.

An interventional cardiologist at Sahlgrenska University Hospital, University of Gothenburg, Department of Clinical Physiology, Institute of Medicine. Features in 1 video on Wondr Medical. Truls Råmunddal generally speaks on Coronary Artery Bypass Grafting (CABG), Chronic Total Occlusion (CTO), and Coronary Interventions.

Works at Södersjukhuset, Stockholm, Sweden. Features in 1 video on Wondr Medical. Ulf Jensen generally speaks on Coronary Artery Bypass Grafting (CABG), Chronic Total Occlusion (CTO), and Coronary Interventions.

Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.